For the Quarter Ending March 2026
Metoclopramide HCL Prices in North America
- In United States, the Metoclopramide HCL Price Index rose quarter-over-quarter in Q1 2026, driven by elevated chemical production costs.
- During March 2026, CPI rose 3.3% and PPI increased 4.0%, elevating the Metoclopramide HCL Production Cost Trend.
- Retail sales grew 4.0% and unemployment held at 4.3% in March 2026, supporting the Metoclopramide HCL Demand Outlook.
- Industrial production grew 0.7% and consumer confidence reached 91.8 in March 2026, tightening overall Metoclopramide HCL supply.
- The Manufacturing Index expanded in March 2026, reflecting stable production capacity for the Metoclopramide HCL Price Index.
- Crude oil feedstock costs strengthened in March 2026, directly increasing the overall Metoclopramide HCL Production Cost Trend.
- Global chemical supply chains faced disruptions in Q1 2026, while EU trade surpluses diminished in Feb 2026.
- Despite softened downstream demand in Q1 2026, the Metoclopramide HCL Price Forecast pointed upward due to tight inventories.
Why did the price of Metoclopramide HCL change in March 2026 in North America?
- Elevated crude oil feedstock costs in March 2026 directly increased Metoclopramide HCL synthesis expenses significantly.
- A 4.0% producer price increase in March 2026 forced manufacturers to pass costs downstream immediately.
- Global supply chain disruptions throughout Q1 2026 constrained availability, driving up Metoclopramide HCL prices consistently.
Metoclopramide HCL Prices in APAC
- In China, the Metoclopramide HCL Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream petrochemical feedstock costs.
- The Metoclopramide HCL Production Cost Trend increased in March 2026 as the Producer Price Index rose 0.5%.
- The Metoclopramide HCL Demand Outlook strengthened in March 2026, supported by a 5.7% expansion in industrial production.
- Consumer prices grew 1.0% in March 2026, while retail sales increased 1.7%, maintaining baseline Metoclopramide HCL consumption.
- An unemployment rate of 5.4% in March 2026 and a 91.6 consumer confidence index in February 2026 constrained retail purchases.
- The Manufacturing Index expanded in March 2026, reflecting robust pharmaceutical sector activity and increased Metoclopramide HCL API procurement.
- Brent crude oil and naphtha feedstock costs surged in March 2026 following maritime chokepoint closures, inflating Metoclopramide HCL expenses.
- The Metoclopramide HCL Price Forecast indicated upward pressure in Q1 2026 due to severe shipment delays and elevated freight.
Why did the price of Metoclopramide HCL change in March 2026 in APAC?
- Toluene, naphtha, and methanol precursor costs surged in March 2026 amid severe trade flow disruptions.
- Brent crude oil prices spiked in March 2026 following military engagements and maritime chokepoint closures.
- The Producer Price Index rose 0.5% in March 2026, reflecting higher factory-gate chemical manufacturing costs.
Metoclopramide HCL Prices in Europe
- In Germany, the Metoclopramide HCL Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- The Metoclopramide HCL Production Cost Trend increased in March 2026 as 2.7% inflation elevated operational expenses.
- Although producer prices declined -0.2% in March 2026, toluene and benzene feedstock costs surged significantly.
- The Manufacturing Index expanded in March 2026, while industrial production remained stagnant at 0.0% in February 2026.
- Retail sales grew 0.7% and unemployment stayed at 4.2% in February 2026, supporting steady pharmaceutical consumption.
- The Metoclopramide HCL Demand Outlook weakened in March 2026 as consumer confidence dropped to a -24.7 index.
- Ammonia precursor costs for Metoclopramide HCL spiked during Q1 2026 amid widespread global supply disruptions.
- Shipping container rates surged in March 2026 as the Strait of Hormuz closure restricted chemical exports.
- The Metoclopramide HCL Price Forecast showed upward pressure in March 2026 due to escalating natural gas costs.
Why did the price of Metoclopramide HCL change in March 2026 in Europe?
- Crude oil and natural gas prices surged in March 2026, inflating chemical production costs significantly.
- European benzene and global ammonia availability tightened in Q1 2026, driving up essential precursor expenses.
- The Strait of Hormuz closure restricted chemical trade flows in March 2026, disrupting regional supply.
For the Quarter Ending December 2025
Metoclopramide HCL Prices in North America
- In the United States, the Metoclopramide HCL Price Index rose quarter-over-quarter in Q4 2025, driven by increasing production costs.
- Consumer Price Index increased 2.7% year-over-year in December 2025, raising raw material and energy costs.
- Producer Price Index climbed 3.0% year-over-year in November 2025, indicating higher input costs for chemical manufacturers.
- Natural gas feedstock costs surged in late 2025 due to a polar vortex, impacting Metoclopramide HCL manufacturing.
- Industrial production increased 2.0% year-over-year in December 2025, supporting the chemical supply chain.
- Retail sales increased 3.3% year-over-year in November 2025, supporting healthcare spending and pharmaceutical demand.
- The pharmaceutical sector experienced a cautious recovery in Q4 2025, with established pharmaceutical sales growing.
- Tariffs on chemical inputs threatened to inflate costs and reshape supply chains during Q4 2025.
Why did the price of Metoclopramide HCL change in December 2025 in North America?
- Rising Producer Price Index (3.0% YoY in November 2025) increased input costs for Metoclopramide HCL production.
- Natural gas feedstock costs surged in late 2025, directly elevating manufacturing expenses for the chemical.
- Increased industrial production (2.0% YoY in December 2025) and growing established pharmaceutical sales supported demand.
Metoclopramide HCL Prices in APAC
- In China, the Metoclopramide HCL Price Index declined in Q4 2025, driven by falling producer prices.
- Metoclopramide HCL production costs decreased in December 2025, as producer prices fell 1.9% year-over-year.
- Demand for Metoclopramide HCL faced pressure in December 2025 due to weak retail sales growth of 0.9%.
- The Manufacturing Index expanded in December 2025, indicating robust industrial activity supporting Metoclopramide HCL supply.
- Industrial production increased 5.2% year-over-year in December 2025, ensuring stable supply for Metoclopramide HCL.
- Consumer sentiment cooled in Q4 2025, contributing to a cautious outlook for Metoclopramide HCL demand.
- Low inflationary pressures, with CPI at 0.8% in December 2025, impacted Metoclopramide HCL manufacturing costs.
- The unemployment rate stood at 5.1% in December 2025, reflecting a stable labor market affecting healthcare spending.
- The Metoclopramide HCL price forecast suggests continued stability or slight declines, given cost and demand dynamics.
Why did the price of Metoclopramide HCL change in December 2025 in APAC?
- Producer prices declined 1.9% in December 2025, reducing Metoclopramide HCL manufacturing costs.
- Weak retail sales growth of 0.9% in December 2025 dampened Metoclopramide HCL demand.
- Expanding manufacturing activity in December 2025 supported robust supply, influencing Metoclopramide HCL prices.
Metoclopramide HCL Prices in Europe
- In Germany, the Metoclopramide HCL Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer prices.
- Metoclopramide HCL production costs faced mixed pressures; producer prices fell 2.5% year-on-year in December 2025.
- Operational costs for Metoclopramide HCL manufacturers increased as consumer prices rose 1.8% year-on-year in December 2025.
- Metoclopramide HCL demand outlook weakened, with the Manufacturing Index showing a contracting trend in December 2025.
- Consumer confidence remained pessimistic at -17.5 index points in December 2025, impacting healthcare spending.
- Industrial production growth was modest at 0.8% year-on-year in October 2025, indicating limited broader industrial expansion.
- The unemployment rate stood at 6.2% in December 2025, potentially constraining healthcare affordability and public funding.
- The Metoclopramide HCL price trend reflected ongoing economic contraction and mixed cost pressures during Q4 2025.
Why did the price of Metoclopramide HCL change in December 2025 in Europe?
- Producer prices fell 2.5% year-on-year in December 2025, reducing Metoclopramide HCL raw material costs.
- The Manufacturing Index contracted in December 2025, signaling weakened overall economic activity.
- Consumer confidence remained low at -17.5 index points in December 2025, impacting healthcare spending.
For the Quarter Ending September 2025
Metoclopramide HCL Prices in North America
- In United States, the Metoclopramide HCL Price Index rose in Q3 2025, driven by increasing production costs.
- Metoclopramide HCL production costs increased in Q3 2025, influenced by a 2.6% PPI rise in August 2025.
- The Metoclopramide HCL Demand Outlook was supported by a resurgence in the pharmaceutical sector in Q3 2025.
- The Metoclopramide HCL Price Forecast suggests continued upward pressure due to anticipated rising production costs.
- US natural gas prices strengthened throughout Q3 2025, impacting Metoclopramide HCL energy and feedstock expenses.
- A 3.0% CPI increase in September 2025 raised raw material and operational costs for Metoclopramide HCL production.
- A 4.3% unemployment rate in September 2025 supported patient access and affordability for Metoclopramide HCL.
- US chemical industry inventories shrank in Q3 2025, reflecting intensified destocking efforts by manufacturers.
Why did the price of Metoclopramide HCL change in September 2025 in North America?
- Production costs for Metoclopramide HCL increased due to a 2.6% PPI rise in August 2025.
- Rising natural gas prices in Q3 2025 contributed to higher energy and feedstock expenses.
- A 3.0% CPI increase in September 2025 elevated raw material and operational costs.
Metoclopramide HCL Prices in APAC
- In China, the Metoclopramide HCL Price Index fell quarter-over-quarter in Q3 2025, influenced by oversupply and deflationary pressures.
- Metoclopramide HCL production costs declined in September 2025, as producer prices fell 2.3% year-on-year.
- Metoclopramide HCL demand supported by 3.0% retail sales growth and 5.2% unemployment in September 2025.
- The Metoclopramide HCL price forecast indicates continued downward pressure due to broad chemical oversupply in Q3 2025.
- The Manufacturing Index contracted in September 2025, signaling economic slowdown impacting the supply chain.
- Robust pharmaceutical manufacturing growth in 2025, driven by aging population, supports Metoclopramide HCL demand.
- Persistent oversupply in the broader chemical sector in Q3 2025, from capacity additions, impacted market balance.
- General chemical feedstock costs remained steady in Q3 2025, despite ongoing high energy cost concerns.
- China's industrial production increased 6.5% year-on-year in September 2025, supporting the manufacturing base.
Why did the price of Metoclopramide HCL change in September 2025 in APAC?
- CPI fell 0.3% and PPI fell 2.3% in September 2025, exerting downward price pressure.
- Persistent oversupply in the broader chemical sector during Q3 2025, driven by capacity additions.
- Contracting Manufacturing Index and low consumer confidence (89.6) in September 2025 signaled caution.
Metoclopramide HCL Prices in Europe
- In Germany, the Metoclopramide HCL Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices.
- Elevated raw material costs and strengthened industrial electricity, influenced by 2.4% CPI, increased production.
- Producer prices for chemical and pharma declined -1.7% year-over-year in September 2025, easing input costs.
- Metoclopramide HCL demand outlook supported by aging population and increasing chronic diseases.
- German industrial production contracted -1.0% year-over-year in September 2025, impacting raw material.
- The Manufacturing Index contracted in Q3 2025, signaling a slowdown across German manufacturing.
- A low unemployment rate of 3.9% in September 2025 supported public healthcare funding and patient access.
- Retail sales grew modestly by 0.8% year-over-year in September 2025, indicating stable consumer spending.
- Consumer confidence at -23.6 in September 2025 indicated pessimistic sentiment, potentially constraining healthcare.
Why did the price of Metoclopramide HCL change in September 2025 in Europe?
- Producer prices for chemical and pharma declined -1.7% year-over-year in Q3 2025, reducing input costs.
- Elevated chemical raw material costs and strengthened industrial electricity prices increased production expenses.
- German chemical industry overcapacities and weakening export demand created competitive pricing.
For the Quarter Ending June 2023
North America
U.S. metoclopramide hydrochloride prices showed a mixed trend in the second quarter of 2023. Prices increased in May slightly by 1.18% because of increased demand from end-users coupled with inventory replenishment activities with fresh stock, which kept the market on the north side. The Manufacturing PMI (Purchasing Managers' Index) came in at 48.4 in May, demonstrating a slowdown in the U.S. manufacturing sector.
This shows that the supply of manufacturers and suppliers has been constrained due to reduced business activity. But consumer demand remained strong, leading to increased metoclopramide hydrochloride prices in May. In contrast, prices fell 4.23% in June compared to May due to exceptionally sluggish offtakes in end-user industries.
Domestic suppliers have abundant Metoclopramide Hydrochloride in their inventory, resulting in continuously falling costs in the domestic market. Additionally, high-interest rates by Federal Reserve interest have reduced the demand for metoclopramide hydrochloride in the market, further supporting the bearish trend. Also, the U.S. dollar appreciated against Chinese yuan in June, increasing imports in the U.S. market, further putting downward pressure on the prices of Metoclopramide HCL.
Asia Pacific
Prices for metoclopramide hydrochloride in China showed mixed trends in the second quarter. Metoclopramide hydrochloride prices rose 1.21% in May, contrasting with April levels due to consistent demand in the domestic market and ongoing operational activity. China's Purchasing Managers Index (PMI) fell to 48.8 in May from 49.2 in April, signaling a slowdown in factory activity, leading to fewer inventories among market manufacturers and suppliers to fulfill the strong demand in the market, pushing the prices upward. In contrast, metoclopramide hydrochloride prices fell 3.21% in June from May as new order follow-up and consumer purchasing activity slowed. The official manufacturing Purchasing Managers Index (PMI) rose to 49.0 in June from 48.8 in the previous month, signaling a slowdown in manufacturing activity. Production decreased due to sluggish end-user demand. However, prices are kept low as market participants hold sufficient inventory to meet existing market demand. Additionally, Chinese exports fell by 12.4% in June, leading to increased availability of metoclopramide hydrochloride on the Chinese market, supporting the downward trend in prices.
Europe
In Germany, the situation of metoclopramide hydrochloride showed a mixed trend throughout the second quarter. Prices rose slightly in May to 1.19% from April, then fell to 4.38% in June. Prices rose in May due to limited stockpiles among traders and suppliers, coupled with increased demand from end-user industries. The manufacturing Purchasing Managers' Index (PMI) for Germany fell to 43.2 in May from 44.5 in April, reflecting weaker business activity, lower inventories among market participants with delays in shipments to meet demand, leading to increase in metoclopramide hydrochloride prices. In June, the German economy was hit by rising inflation and an interest rate hike by the European Central Bank, leading to higher food and energy prices. This has increased the cost of living and reduced consumer purchasing activity, supporting the downward trend in the price of metoclopramide hydrochloride. Furthermore, the appreciation of the Euro against the U.S. Dollar in June made imports cheaper and also increased the supply of metoclopramide hydrochloride in the German market. This puts further downward pressure on the prices.
